Inventurus Knowledge Solutions Limited (IN:IKS)
:IKS
Want to see IN:IKS full AI Analyst Report?
Top Page
Inventurus Knowledge Solutions Limited
(IKS)
Select Model
Select Model
Rating:76Outperform
Price Target:
₹1,893.00
▲(13.13% Upside)
Action:Reiterated
Date:05/15/26
The score is driven primarily by strong recent financial results (growth and profitability) and clear bullish technical trend/momentum. This is tempered by elevated valuation (P/E ~30.8) and some financial quality concerns from historical margin inconsistency and softer recent operating cash flow coverage.
Positive Factors
Revenue and margin strength
Consistent double‑digit revenue growth together with high operating (~32%) and net (~23%) margins indicates a scalable, profitable healthcare BPO model. Durable margin and earnings strength supports reinvestment, staffing and competitive positioning over the next several quarters.
Negative Factors
Margin volatility and data inconsistency
Marked variability in margins and reported profit metrics across years weakens confidence in sustainable profitability. Persistent swings complicate forecasting, pricing and capacity planning for a contract services business and raise execution and modeling risk over the medium term.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue and margin strength
Consistent double‑digit revenue growth together with high operating (~32%) and net (~23%) margins indicates a scalable, profitable healthcare BPO model. Durable margin and earnings strength supports reinvestment, staffing and competitive positioning over the next several quarters.
Read all positive factors
Inventurus Knowledge Solutions Limited (IKS) vs. iShares MSCI India ETF (INDA)
Market Cap
₹280.17B
Dividend YieldN/A
Average Volume (3M)4.58K
Price to Earnings (P/E)38.9
Beta (1Y)0.81
Revenue GrowthN/A
EPS GrowthN/A
CountryIN
Employees7,530
SectorServices
Sector StrengthN/A
IndustryMedical - Healthcare Information Services
Share Statistics
EPS (TTM)31.90
Shares Outstanding171,573,170
10 Day Avg. Volume2,488
30 Day Avg. Volume4,579
Financial Highlights & Ratios
PEG Ratio0.65
Price to Book (P/B)7.94
Price to Sales (P/S)6.96
P/FCF Ratio37.04
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
₹1,725.00Price Target Upside3.09% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
EPS Forecast (FY)55.05
Revenue Forecast (FY)₹43.69B
Inventurus Knowledge Solutions Limited Business Overview & Revenue Model
Company Description
Inventurus Knowledge Solutions Ltd. engages in the provision of coding and scribe services, and delivering medical transcriptions. It operates through its sole segment of Healthcare. The Healthcare segment represents providing focused cost and pro...
How the Company Makes Money
IKS primarily makes money by providing outsourced, contract-based services to healthcare clients and billing for those services under commercial arrangements such as recurring service fees (e.g., monthly/term-based fees) and/or transaction/volume-...
Inventurus Knowledge Solutions Limited Financial Statement Overview
Summary
Income Statement
83
Very Positive
Balance Sheet
72
Positive
Cash Flow
68
Positive
| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 27.63B | 31.94B | 26.64B | 18.17B | 10.31B | 7.64B |
| Gross Profit | 8.37B | 14.41B | 26.63B | 18.16B | 5.05B | 3.59B |
| EBITDA | 8.47B | 11.54B | 8.09B | 5.61B | 3.89B | 2.98B |
| Net Income | 5.33B | 7.22B | 4.86B | 3.70B | 3.05B | 2.33B |
Balance Sheet | ||||||
| Total Assets | 0.00 | 42.68B | 30.52B | 30.28B | 9.88B | 7.88B |
| Cash, Cash Equivalents and Short-Term Investments | 1.92B | 6.09B | 2.19B | 4.83B | 5.23B | 3.47B |
| Total Debt | 0.00 | 7.53B | 8.56B | 13.11B | 523.46M | 651.92M |
| Total Liabilities | -17.90B | 14.68B | 12.62B | 18.70B | 1.60B | 1.40B |
| Stockholders Equity | 17.90B | 28.00B | 17.90B | 11.58B | 8.29B | 6.47B |
Cash Flow | ||||||
| Free Cash Flow | 1.06B | 6.00B | 2.93B | 1.77B | 2.79B | 2.22B |
| Operating Cash Flow | 1.19B | 6.32B | 3.18B | 2.10B | 2.88B | 2.33B |
| Investing Cash Flow | 1.42B | -2.15B | 2.44B | -11.41B | -1.56B | -824.48M |
| Financing Cash Flow | -1.37B | -3.65B | -3.89B | 7.80B | -1.52B | -585.10M |
Inventurus Knowledge Solutions Limited Technical Analysis
Positive
1673.35
Price Trends
1509.07
Positive
1548.69
Positive
1568.30
Positive
Market Momentum
31.09
Positive
58.99
Neutral
69.96
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:IKS, the sentiment is Positive. The current price of 1673.35 is above the 20-day moving average (MA) of 1654.25, above the 50-day MA of 1509.07, and above the 200-day MA of 1568.30, indicating a bullish trend. The MACD of 31.09 indicates Positive momentum. The RSI at 58.99 is Neutral, neither overbought nor oversold. The STOCH value of 69.96 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IN:IKS.
Inventurus Knowledge Solutions Limited Peers Comparison
UnderperformOutperform
Sector (55)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | ₹280.17B | 38.85 | ― | ― | ― | ― | |
74 Outperform | ₹142.19B | 19.75 | ― | 0.02% | 22.32% | 32.16% | |
71 Outperform | ₹83.27B | 37.24 | ― | ― | 21.55% | 64.47% | |
65 Neutral | ₹182.93B | 26.92 | ― | 1.13% | 19.75% | 13.19% | |
55 Neutral | $13.29B | 17.42 | 10.03% | 0.93% | 7.13% | -12.93% | |
55 Neutral | ₹19.20B | 43.38 | ― | 1.51% | 0.97% | -78.30% | |
54 Neutral | ₹53.06B | 30.09 | ― | 0.40% | 7.52% | -16.28% |
* Services Sector Average
IN:IKS
Inventurus Knowledge Solutions Limited
1,672.55
152.40
10.03%
IN:CARTRADE
CarTrade Tech Ltd.
1,737.30
228.15
15.12%
IN:ECLERX
eClerx Services Limited
1,511.85
-220.07
-12.71%
IN:FSL
Firstsource Solutions Limited
262.45
-107.18
-29.00%
IN:HGS
Hinduja Global Solutions Limited
412.80
-93.40
-18.45%
IN:IONEXCHANG
Ion Exchange (India) Ltd.
361.80
-180.47
-33.28%
Inventurus Knowledge Solutions Limited Corporate Events
Inventurus Knowledge Solutions Sets Q4 FY 2025-26 Earnings Call for May 14
May 9, 2026
Inventurus Knowledge Solutions Limited has announced the schedule for its earnings conference call to discuss financial results for the fourth quarter of fiscal year 2025-26, to be held on Thursday, May 14, 2026, at 8:30 a.m. India Standard Time. ...
IKS Health Posts Conference Call Audio on TruBridge Acquisition
Apr 24, 2026
Inventurus Knowledge Solutions Limited has notified the stock exchanges that an audio recording of its recent conference call discussing the agreement by IKS Health to acquire TruBridge is now available on the company’s website. The disclosu...
IKS Health Shares Investor FAQs on Planned TruBridge Acquisition
Apr 24, 2026
Inventurus Knowledge Solutions Limited has notified the stock exchanges that it has issued an investor-focused FAQ document related to its previously announced agreement for IKS Health to acquire TruBridge. The FAQs are intended to address common ...
IKS Health Unveils Investor Presentation on TruBridge Acquisition Agreement
Apr 23, 2026
IKS Health has announced that it has reached an agreement to acquire TruBridge, and has released an investor conference call presentation detailing the transaction. The presentation has been shared with stock exchanges and posted on the company...
IKS Health to Acquire TruBridge in Push to Bolster Rural U.S. Healthcare
Apr 23, 2026
IKS Health has agreed to acquire TruBridge, a U.S. provider of healthcare technology for rural and community hospitals, in a move that expands its reach across local healthcare systems and strengthens access to care closer to home. By combining IK...
IKS Health Launches AI-Driven MyCareHub to Transform Patient Engagement and Boost Collections
Apr 15, 2026
IKS Health has launched MyCareHub, an agentic AI, self-orchestrating patient engagement platform unveiled at the 2026 American Medical Group Association conference. The platform integrates with Epic via the Epic Connection Hub and uses multi-agent...
Inventurus Knowledge Solutions Files SEBI Dematerialisation Compliance Certificate
Apr 10, 2026
Inventurus Knowledge Solutions Limited has disclosed that it received a compliance certificate from its registrar and share transfer agent, MUFG Intime India Private Limited, for the quarter ended March 31, 2026 under Regulation 74(5) of the SEBI ...
Inventurus Knowledge Solutions Injects USD 19 Million into U.S. Subsidiary
Mar 27, 2026
Inventurus Knowledge Solutions Limited has increased its stake in its wholly owned subsidiary, Inventurus Knowledge Solutions, Inc., by acquiring 29,541 shares in a first investment tranche valued at USD 19,000,476. This follow-on capital deployme...
Inventurus Knowledge Solutions to Invest Up to USD 40 Million in Healthcare Tech Subsidiary
Mar 13, 2026
Inventurus Knowledge Solutions Limited has approved a further investment of up to USD 40 million in its wholly owned U.S. subsidiary Inventurus Knowledge Solutions Inc., which operates a care enablement platform for healthcare providers. The trans...
Inventurus Knowledge Solutions Grants 600,000 Stock Options Under 2022 ESOP
Mar 5, 2026
Inventurus Knowledge Solutions Limited has granted 600,000 employee stock options under its 2022 Employee Stock Option Plan, following approval by the Nomination and Remuneration Committee on March 5, 2026. Each option is convertible into one equi...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.